ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · IEX Real-Time Price · USD
13.16
+0.08 (0.61%)
At close: Jul 26, 2024, 4:00 PM
13.13
-0.03 (-0.23%)
After-hours: Jul 26, 2024, 6:59 PM EDT
ADMA Biologics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2013 |
---|---|---|---|---|---|---|---|
Cash & Equivalents | 45.33 | 51.35 | 86.52 | 51.09 | 55.92 | 26.75 | Upgrade
|
Cash & Short-Term Investments | 45.33 | 51.35 | 86.52 | 51.09 | 55.92 | 26.75 | Upgrade
|
Cash Growth | -34.51% | -40.65% | 69.36% | -8.64% | 109.03% | 17.57% | Upgrade
|
Receivables | 49.62 | 27.42 | 15.51 | 28.58 | 13.24 | 3.47 | Upgrade
|
Inventory | 177.73 | 172.91 | 163.28 | 124.72 | 81.54 | 53.06 | Upgrade
|
Prepaid Expenses | 3.74 | 5.33 | 5.1 | 4.34 | 3.05 | 2.53 | Upgrade
|
Total Current Assets | 276.42 | 257.01 | 270.4 | 208.73 | 153.74 | 85.82 | Upgrade
|
Property, Plant & Equipment | 64.71 | 63.47 | 68.75 | 58.2 | 45.85 | 32.99 | Upgrade
|
Goodwill | 3.53 | 3.53 | 3.53 | 3.53 | 3.53 | 3.53 | Upgrade
|
Other Intangible Assets | 0.32 | 0.5 | 1.01 | 1.73 | 2.44 | 3.16 | Upgrade
|
Other Long-Term Assets | 5.89 | 4.67 | 4.77 | 4.07 | 2.11 | 1.6 | Upgrade
|
Total Assets | 350.88 | 329.18 | 348.46 | 276.25 | 207.67 | 127.09 | Upgrade
|
Accounts Payable | 17.19 | 15.66 | 13.23 | 12.43 | 11.07 | 9.17 | Upgrade
|
Accrued Expenses | 31.31 | 30.01 | 23.19 | 16.23 | 8.16 | 3.84 | Upgrade
|
Current Portion of Leases | 1.09 | 1.05 | 0.91 | 0.59 | 0.37 | 0.23 | Upgrade
|
Current Unearned Revenue | 1.12 | 0.18 | 0.14 | 0.14 | 0.14 | 0.14 | Upgrade
|
Other Current Liabilities | 2.38 | 2.91 | 1.8 | 0.98 | 0.21 | 0.64 | Upgrade
|
Total Current Liabilities | 53.09 | 49.81 | 39.27 | 30.38 | 19.95 | 14.03 | Upgrade
|
Long-Term Debt | 130.85 | 130.59 | 142.83 | 94.87 | 92.97 | 83.2 | Upgrade
|
Long-Term Leases | 9.49 | 9.78 | 10.7 | 7.46 | 4.33 | 1.3 | Upgrade
|
Long-Term Unearned Revenue | 1.65 | 1.69 | 1.83 | 1.98 | 2.12 | 2.26 | Upgrade
|
Other Long-Term Liabilities | 2.09 | 2.11 | 1.85 | 0.4 | 0.05 | 0.11 | Upgrade
|
Total Liabilities | 197.17 | 193.98 | 196.49 | 135.08 | 119.42 | 100.9 | Upgrade
|
Common Stock | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | Upgrade
|
Additional Paid-In Capital | 642.13 | 641.44 | 629.97 | 553.27 | 428.7 | 290.9 | Upgrade
|
Retained Earnings | -488.45 | -506.26 | -478.02 | -412.11 | -340.47 | -264.72 | Upgrade
|
Shareholders' Equity | 153.71 | 135.21 | 151.97 | 141.17 | 88.25 | 26.19 | Upgrade
|
Total Liabilities & Equity | 350.88 | 329.18 | 348.46 | 276.25 | 207.67 | 127.09 | Upgrade
|
Total Debt | 141.43 | 141.42 | 154.44 | 102.92 | 97.67 | 84.73 | Upgrade
|
Net Cash (Debt) | -96.1 | -90.07 | -67.92 | -51.83 | -41.75 | -57.98 | Upgrade
|
Net Cash Per Share | -0.43 | -0.40 | -0.34 | -0.37 | -0.48 | -1.07 | Upgrade
|
Filing Date Shares Outstanding | 231.81 | 228.22 | 222.16 | 195.92 | 121.28 | 86.35 | Upgrade
|
Total Common Shares Outstanding | 231.77 | 226.06 | 221.82 | 195.81 | 104.9 | 59.32 | Upgrade
|
Working Capital | 223.33 | 207.21 | 231.14 | 178.35 | 133.79 | 71.79 | Upgrade
|
Book Value Per Share | 0.66 | 0.60 | 0.69 | 0.72 | 0.84 | 0.44 | Upgrade
|
Tangible Book Value | 149.86 | 131.18 | 147.43 | 135.91 | 82.28 | 19.5 | Upgrade
|
Tangible Book Value Per Share | 0.65 | 0.58 | 0.66 | 0.69 | 0.78 | 0.33 | Upgrade
|
Land | 4.34 | 4.34 | 4.34 | 4.34 | 4.34 | 4.34 | Upgrade
|
Buildings | 20.71 | 20.22 | 19.54 | 19.07 | 17.4 | 16.06 | Upgrade
|
Machinery | 33.44 | 32.93 | 29.2 | 24.17 | 20.11 | 11.1 | Upgrade
|
Construction In Progress | 4.45 | 2.27 | 6.73 | 5.5 | 3.34 | 4.29 | Upgrade
|
Leasehold Improvements | 21.03 | 20.81 | 17.93 | 11.13 | 5.27 | 1.67 | Upgrade
|
Source: S&P Capital IQ. Standard template.